IL4R and head and neck carcinoma: The overexpression of IL-4Rα in tumor cells is usually associated with poor prognosis in some human cancer (bladder, head–neck carcinomas, etc.)[140,141], suggesting that IL-4Rα-targeted therapy would be appropriate for advanced/stage tumors.